ACRV icon

Acrivon Therapeutics
ACRV

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13.5
622% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
Edward Tenthoff
0% 1-yr ACRV win rate
9 Jan ‘26 7 days ago
HC Wainwright & Co
HC Wainwright & Co
Emily Bodnar
0% 1-yr ACRV win rate
25 Nov ‘25 1 month ago